Morepen Laboratories LimitedNSE: MOREPENLAB

Press Release Dec 03 2021

· Issued by Morepen Laboratories Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-03-2021-8

Morepen Laboratories Limited has informed the Exchange regarding a press release dated December 03, 2021, titled "Morepen gets US FDA Approval for Fexofinadine (Allegra) Expected to start export in Q4 FY22".

View Attachment

6ix hasn’t read this filing yet.

Morepen Laboratories Limited on 6ix

Earlier from Morepen Laboratories

Later from Morepen Laboratories

All Morepen Laboratories news releases